Funding To Address Drug Resistance Requires Public, Private Cooperation, Experts Agree

BBC News: How should the fight against drug resistance be funded?
“… ‘Better infection prevention and control in health care settings; a focus on hygiene and sanitation; where appropriate, increasing vaccination uptake,’ says Dr. Charles Penn, the World Health Organization (WHO) coordinator for antimicrobial resistance. All of which would reduce the reliance on antibiotics, he argues. New drugs need to be available to all, but they should be used ‘wisely and appropriately’ so that they remain effective for ‘as long as possible,’ he says. Most experts agree that cooperation between the private and public sectors will be essential to prevent millions of additional fatalities over the coming decades…” (Wall, 5/2).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.